TRPA1 and colitis: Colitis rats supplemented with 12 mg CAP/kg bw for 4 weeks decrease serum IL-6 levels and protein expression of TRPV1 and TRPA1 in the colon, and increase serum SOD and CAT activities and colonic IL-10 levels.